SCHEMBL8314501

SCHEMBL8314501

CN1C(=O)CCCC[C@H]1c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
TSHR P16473 2/20 0.53
KMT2A Q03164 2/20 0.53
CYP3A4 P08684 1/20 0.53
THRB P10828 1/20 0.53
THPO P40225 1/20 0.53
MEN1 O00255 1/20 0.53
MAPK1 P28482 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
CHRNB2 P17787 1/20 0.51
CHRNB4 P30926 1/20 0.51
CHRNA3 P32297 1/20 0.51
CHRNA7 P36544 1/20 0.51
CHRNA4 P43681 1/20 0.51
SLC18A3 Q16572 1/20 0.49
SRD5A1 P18405 1/20 0.46
BRD4 O60885 3/20 0.45
ALDH1A1 P00352 1/20 0.44
ATM Q13315 1/20 0.44
RIPK1 Q13546 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25017793 1.00 KDM4E (0.53) KDM4ETSHRKMT2ACYP3A4THRB
SCHEMBL1240108 0.95 KDM4E (0.54) KDM4ETSHRKMT2ACYP3A4THRB
SCHEMBL11708369 0.87 KDM4E (0.66) KDM4ETSHRKMT2ACYP3A4THRB
SCHEMBL13225803 0.87 KDM4E (0.66) KDM4ETSHRKMT2ACYP3A4THRB
SCHEMBL1830591 0.79 SLC18A3 (0.46) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL25017792 0.79 SLC18A3 (0.46) TSHRKMT2ACHRNB2CHRNB4CHRNA3
SCHEMBL23562447 0.79 CHRM2 (0.50) KMT2AMEN1CHRNB2CHRNB4CHRNA3
SCHEMBL5762092 0.78 BRD4 (0.56) KDM4ETSHRKMT2ACYP3A4THRB
SCHEMBL12918110 0.77 CHRNB2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL11666714 0.76 SLC18A3 (0.56) KMT2AMEN1CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004080983-A1 NOVEL LACTAMS AND USES THEREOF ASTRAZENECA AB (SE) 2004-09-23 WO disclosed